Skip to content
PICO Portalanswers from OpenAlex

Cetuximab Combined with Vemurafenib Can Significantly Inhibit the Proli- Feration Of Braf V600e Mutant Egfr Wild-Type Colorectal Cancer Cells

PaperCitations, authors & open-access status

Cetuximab Combined with Vemurafenib Can Significantly Inhibit the Proli- Feration Of Braf V600e Mutant Egfr Wild-Type Colorectal Cancer Cells is a paper indexed in PICO Portal from OpenAlex.

How many citations does Cetuximab Combined with Vemurafenib Can Significantly Inhibit the Proli- Feration Of Braf V600e Mutant Egfr Wild-Type Colorectal Cancer Cells have?

PICO Portalcitation count

Cetuximab Combined with Vemurafenib Can Significantly Inhibit the Proli- Feration Of Braf V600e Mutant Egfr Wild-Type Colorectal Cancer Cells has 0 citations in the OpenAlex counts PICO Portal stores.

When was Cetuximab Combined with Vemurafenib Can Significantly Inhibit the Proli- Feration Of Braf V600e Mutant Egfr Wild-Type Colorectal Cancer Cells published?

PICO Portalyear

Cetuximab Combined with Vemurafenib Can Significantly Inhibit the Proli- Feration Of Braf V600e Mutant Egfr Wild-Type Colorectal Cancer Cells has 2020 year in the PICO Portal index.

What is the open-access status of Cetuximab Combined with Vemurafenib Can Significantly Inhibit the Proli- Feration Of Braf V600e Mutant Egfr Wild-Type Colorectal Cancer Cells?

PICO Portaloa status

Cetuximab Combined with Vemurafenib Can Significantly Inhibit the Proli- Feration Of Braf V600e Mutant Egfr Wild-Type Colorectal Cancer Cells has closed oa status in the PICO Portal index.

What is the DOI of Cetuximab Combined with Vemurafenib Can Significantly Inhibit the Proli- Feration Of Braf V600e Mutant Egfr Wild-Type Colorectal Cancer Cells?

PICO Portaldoi

The DOI for Cetuximab Combined with Vemurafenib Can Significantly Inhibit the Proli- Feration Of Braf V600e Mutant Egfr Wild-Type Colorectal Cancer Cells is on the source record.

What is the OpenAlex record for Cetuximab Combined with Vemurafenib Can Significantly Inhibit the Proli- Feration Of Braf V600e Mutant Egfr Wild-Type Colorectal Cancer Cells?

PICO Portalopenalex

The OpenAlex for Cetuximab Combined with Vemurafenib Can Significantly Inhibit the Proli- Feration Of Braf V600e Mutant Egfr Wild-Type Colorectal Cancer Cells is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial